Medication tracking
A system and method is described for printing a label with an RFID tag. The system includes an RFID reader that queries a first RFID tag coupled to a first medicinal container that includes a medication. In response, the system receives a first unique identifier and uses the first unique identifier to determine a status of the medication, associate the first medicinal container with a medical provider and print a second label that includes a second RFID tag for a second medicinal container.
1. A system comprising:
an RFID reader coupled to a pharmaceutical item storage unit and configured to query an RFID tag of a label coupled to a medicinal container including a drug and receive a unique identifier from the RFID tag, wherein the unique identifier uniquely identifies the medicinal container from other medicinal containers, wherein the label comprises a transparent portion including an adhesive, an RFID portion that includes the RFID tag and does not include an adhesive, a first opaque portion comprising an adhesive and a second opaque portion comprising an adhesive, wherein a length of the transparent portion extends along a length of the RFID portion and the at least a portion of the medication data is printed onto the RFID portion, and a name of the drug is printed on the first opaque portion and the second opaque portion, and wherein the first opaque portion and the second opaque portion are detachably coupled to the RFID portion; and
a computing device coupled to the RFID reader and configured to:
receive the unique identifier,
query a remotely located database for drug data of the drug using the unique identifier, wherein the drug data indicates that the drug is at least one of a multi-dose drug, a drug for refrigeration, or a liquid drug, wherein the medical container for a multi-dose drug comprises a seal, wherein the medical container for a liquid drug comprises a vial or a syringe,
receive drug usage information based on user input, wherein the drug usage information comprises at least one of an indication that the seal is broken or punctured, an indication of a date that the seal was broken or punctured, an indication that the drug for refrigeration is un-refrigerated, an indication of a date that the refrigerated drug was un-refrigerated, an indication that the drug is contained in the syringe, or an indication of a date that the drug was transferred to the syringe,
verify an actual expiration date of the drug, wherein to verify the actual expiration date of the drug, the computing device is configured to:
determine a first expiration date based at least in part on the drug data, wherein the first expiration date corresponds to at least one of an expiration based on a sealed seal, an expiration based on refrigeration, or an expiration based on a vial expiration,
determine a second expiration date based at least in part on the drug usage information, wherein the second expiration date corresponds to at least one of an expiration based on based on a broken seal, an expiration based on non-refrigeration, or an expiration based on a syringe expiration, and
identify the actual expiration date, wherein the actual expiration date is the earlier of the first expiration date and the second expiration date, and
update the drug data of the remotely located database to associate the actual expiration date with the unique identifier and mark the drug as an opened, un-refrigerated, or syringe drug.
2. A system comprising:
an RFID reader coupled to a pharmaceutical item storage unit and configured to query a RFID tag of a label coupled to a medicinal container including a drug and receive a unique identifier from the RFID tag, wherein the unique identifier uniquely identifies the medicinal container from all other medicinal containers; and
a computing device coupled to the RFID reader and configured to:
receive the unique identifier,
query a remotely located database for drug data of the drug using the unique identifier,
receive drug usage information,
verify an actual expiration date of the drug, wherein to verify the actual expiration date of the drug, the computing device is configured to:
determine a first expiration date based at least in part on the drug data,
determine a second expiration date based at least in part on the drug usage information, and
identify the actual expiration date, wherein the actual expiration date is the earlier of the first expiration date and the second expiration date, and
update the drug data of the remotely located database to associate the actual expiration date with the unique identifier.
3. The system of claim 2 , wherein the drug data indicates that the drug is at least one of a multi-dose drug, a drug for refrigeration, or a liquid drug, wherein the medical container for a multi-dose drug comprises a seal, wherein the medical container for a liquid drug comprises a vial or a syringe.
4. The system of claim 2 , wherein the drug is a multi-dose drug, the medical container comprises a seal, the first expiration date corresponds to an expiration based on a sealed seal, and the second expiration date corresponds to an expiration based on based on a broken seal.
5. The system of claim 4 , wherein the drug usage information comprises at least one of an indication that the seal is broken or punctured and/or an indication of a date that the seal was broken or punctured.
6. The system of claim 2 , wherein the drug is a drug for refrigeration, the first expiration date corresponds to an expiration based on refrigeration, and the second expiration date corresponds to a different expiration based on non-refrigeration.
7. The system of claim 6 , wherein the drug usage information comprises an indication that the drug for refrigeration is un-refrigerated and/or an indication of a date that the refrigerated drug was un-refrigerated.
8. The system of claim 2 , wherein the drug is a fluid, the medical container for comprises a vial or a syringe, the first expiration date corresponds to an expiration based on a vial expiration, and the second expiration date corresponds to an expiration based on a syringe expiration.
9. The system of claim 8 , wherein the drug usage information comprises an indication that the drug is contained in the syringe and/or an indication of a date that the drug was transferred to the syringe.
10. The system of claim 2 , wherein the drug data comprises a drug name, concentration, and total amount of the drug in the medicinal container.
11. The system of claim 2 , wherein the label comprises a transparent portion including an adhesive, an RFID portion that includes the RFID tag and does not include an adhesive, a first opaque portion comprising an adhesive and a second opaque portion comprising an adhesive, wherein a length of the transparent portion extends along a length of the RFID portion and the at least a portion of the medication data is printed onto the RFID portion, and a name of the drug is printed on the first opaque portion and the second opaque portion, and wherein the first opaque portion and the second opaque portion are detachably coupled to the RFID portion.
12. The system of claim 2 , wherein the computing device is further configured to generate a notification that the drug is expired based at least in part on the actual expiration date.
13. A method comprising:
querying an RFID tag of a label coupled to a medicinal container, the medicinal container including a medication;
receiving a unique identifier from the RFID tag, wherein the unique identifier uniquely identifies the medicinal container from other medicinal containers in a pharmaceutical item storage unit;
querying a remotely located database for medication data of the medication using the unique identifier;
receiving medication usage information;
verifying an actual expiration date of the medication, wherein said verifying comprises:
determining a first expiration date based at least in part on the medication data,
determining a second expiration date based at least in part on the medication usage information, and
identifying the actual expiration date, wherein the actual expiration date is the earlier of the first expiration date and the second expiration date; and
updating the medication data of the remotely located database to associate the actual expiration date with the unique identifier.
14. The method of claim 13 , wherein the drug data indicates that the drug is at least one of a multi-dose drug, a drug for refrigeration, or a liquid drug, wherein the medical container for a multi-dose drug comprises a seal, wherein the medical container for a liquid drug comprises a vial or a syringe.
15. The system of claim 13 , wherein the drug is a multi-dose drug, the medical container comprises a seal, the first expiration date corresponds to an expiration based on a sealed seal, and the second expiration date corresponds to an expiration based on based on a broken seal.
16. The system of claim 15 , wherein the drug usage information comprises at least one of an indication that the seal is broken or punctured and/or an indication of a date that the seal was broken or punctured.
17. The system of claim 13 , wherein the drug is a drug for refrigeration, the first expiration date corresponds to an expiration based on refrigeration, and the second expiration date corresponds to a different expiration based on non-refrigeration.
18. The system of claim 17 , wherein the drug usage information comprises an indication that the drug for refrigeration is un-refrigerated and/or an indication of a date that the refrigerated drug was un-refrigerated.
19. The system of claim 13 , wherein the drug is a fluid, the medical container for comprises a vial or a syringe, the first expiration date corresponds to an expiration based on a vial expiration, and the second expiration date corresponds to an expiration based on a syringe expiration.
20. The system of claim 19 , wherein the drug usage information comprises an indication that the drug is contained in the syringe and/or an indication of a date that the drug was transferred to the syringe.